Oncology Institute Inc (NASDAQ: TOI) is 709.06% higher on its value in year-to-date trading and has touched a low of $0.13 and a high of $3.50 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The TOI stock was last observed hovering at around $2.91 in the last trading session, with the day’s loss setting it -0.41%.
Currently trading at $2.50, the stock is 21.18% and 85.36% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.0 million and changing -14.09% at the moment leaves the stock 293.61% off its SMA200. TOI registered 111.86% gain for a year compared to 6-month gain of 662.20%. The firm has a 50-day simple moving average (SMA 50) of $1.34874 and a 200-day simple moving average (SMA200) of $0.63517.
The stock witnessed a 119.30% loss in the last 1 month and extending the period to 3 months gives it a 216.42%, and is -7.75% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 21.15% over the week and 22.02% over the month.
Oncology Institute Inc (TOI) has around 825 employees, a market worth around $189.38M and $393.41M in sales. Profit margin for the company is -13.47%. Distance from 52-week low is 1895.21% and -28.57% from its 52-week high. The company has generated returns on investments over the last 12 months (-44.16%).
.
Oncology Institute Inc (TOI) Top Institutional Holders
37.0 institutions hold shares in Oncology Institute Inc (TOI), with institutional investors hold 41.84% of the company’s shares. The shares outstanding are 75.74M, and float is at 32.51M with Short Float at 4.15%. Institutions hold 35.76% of the Float.
The top institutional shareholder in the company is FMR LLC with over 4.75 million shares valued at $2.19 million. The investor’s holdings represent 6.4005% of the TOI Shares outstanding. As of 2024-06-30, the second largest holder is DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) with 3.36 million shares valued at $1.55 million to account for 4.5263 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 1.78 million shares representing 2.4025% and valued at over $0.82 million, while KENT LAKE CAPITAL LLC holds 2.3574 of the shares totaling 1.75 million with a market value of $0.81 million.
Oncology Institute Inc (TOI) Insider Activity
The most recent transaction is an insider purchase by Virnich Daniel, the company’s Chief Executive Officer. SEC filings show that Virnich Daniel bought 22,640 shares of the company’s common stock on Mar 26 ’25 at a price of $1.04 per share for a total of $23584.0. Following the purchase, the insider now owns 0.72 million shares.
Oncology Institute Inc disclosed in a document filed with the SEC on Mar 26 ’25 that Podnos Yale (Chief Medical Officer) bought a total of 9,056 shares of the company’s common stock. The trade occurred on Mar 26 ’25 and was made at $1.04 per share for $9434.0. Following the transaction, the insider now directly holds 79049.0 shares of the TOI stock.
Still, SEC filings show that on Mar 26 ’25, Pacala Mark L (Director) acquired 90,562 shares at an average price of $1.04 for $94338.0. The insider now directly holds 224,971 shares of Oncology Institute Inc (TOI).
